Key Insights

Highlights

Treatment Research

4 treatments under study, led by Lymph Node Or Core Needle Biopsy

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 2 (1)

Trial Status

Recruiting2

Clinical Trials (2)

Showing 2 of 2 trials
NCT06052618Phase 2Recruiting

Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)

NCT07793006Not ApplicableRecruiting

New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease

Showing all 2 trials

Research Network

Common Treatments

  • Lymph Node Or Core Needle Biopsy1
  • Tiny Isothermal Nucleic Acid Amplification System Tiny1
  • Fine Needle Aspiration1
  • Pacritinib1

Active Sponsors

  • National Institutes of Health (NIH)1
  • UNC Lineberger Comprehensive Cancer Center1
  • National Cancer Institute (NCI)1
  • Indiana University1

Top Investigators

Related Conditions

  • Hodgkin Lymphoma1
  • Lymphadenopathy1
  • Nonhodgkin Lymphoma1
  • Hiv1
  • Kshv Inflammatory Cytokine Syndrome Kics1

Activity Timeline